Utah Medical Products Inc (UTMD)
R&D Expense Growth
0.00%
Quarterly · Period ending:
UTMD R&D Expense Growth
Latest reported0.00%period ending
Latest reported0.00%period ending
UTMD Quarterly R&D Growth (QoQ) (0.00% → 0.00%)
Latest values, visible window
High-resolution chart · PNG
UTMD r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 0% | |
| -27.3585% | |
| 26.9461% | |
| 23.7037% | |
| -12.9032% | |
| 28.0992% | |
| -29.6512% | |
| -32.549% | |
| -4.1353% | |
| 82.1918% | |
| 5.7971% | |
| 3.7594% | |
| -7.6389% | |
| 17.0732% | |
| 9.8214% | |
| -17.037% | |
| 9.7561% | |
| -12.766% | |
| 11.0236% | |
| -0.7813% | |
| -1.5385% | |
| 17.1171% | |
| -11.2% | |
| 7.7586% | |
| -14.0741% | |
| 7.1429% | |
| -3.0769% | |
| 15.0442% | |
| -1.7391% | |
| -0.8621% | |
| 7.4074% | |
| -7.6923% | |
| 3.5398% | |
| 6.6038% | |
| 2.9126% | |
| -13.4454% | |
| 0.8475% | |
| 6.3063% | |
| -17.7778% | |
| 13.4454% | |
| 8.1818% | |
| -5.1724% | |
| 5.4545% | |
| -21.4286% | |
| -10.2564% | |
| 44.4444% | |
| -6.087% | |
| 0% | |
| -6.5041% | |
| 0% | |
| -2.381% | |
| 5% | |
| -2.439% | |
| -5.3846% | |
| -7.1429% | |
| -4.7619% | |
| 0.6849% | |
| 10.6061% | |
| -4.3478% | |
| -6.7568% | |
| 46.5347% | |
| -3.8095% | |
| 3.9604% | |
| 6.3158% | |
| 0% | |
| 7.9545% | |
| -9.2784% | |
| 11.4943% | |
| -2.2472% | |
| 15.5844% | |
| -23% | |
| 11.1111% | |
| -2.1739% | |
| 3.3708% | |
| 1.1364% | |
| -19.2661% | |
| 13.5417% | |
| 304.2553% | |
| -158.0247% | |
| -62.3256% | |
| 216.1765% | |
| -28.4211% | |
| 15.8537% | |
| 3.7975% | |
| 23.4375% | |
| -14.6667% | |
| 7.1429% | |
| -14.6341% | |
| 26.1538% | |
| -8.4507% | |
| -5.3333% | |
| 10.2941% | |
| -6.8493% | |
| -12.0482% | |
| 9.2105% | |
| 11.7647% | |
| 17.2414% | |
| -30.9524% | |
| -2.3256% | |
| -8.5106% |